Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Journal of Movement Disorders|September 18, 2020
Perry Disease: Concept of a New Disease and Clinical Diagnostic CriteriaYoshio Tsuboi, Takayasu Mishima, Shinsuke FujiokaExpert Opinion on Drug Safety|October 1, 2021
Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson's diseaseKanako Kurihara, Takayasu Mishima, Shinsuke Fujioka, et al.Frontiers in Neurology|January 22, 2024
Impact of weight loss for depressive symptom in mid-stage patients with Parkinson's disease: a 4-year follow-up studyKanako Kurihara, Shinsuke Fujioka, Takayasu Mishima, et al.Rinsho Shinkeigaku = Clinical Neurology|April 29, 2025
[Factors associated with fatigue in patients with Parkinson's disease]Kanako Kurihara, Takayasu Mishima, Koichi Nagaki, et al.Frontiers in Neurology|May 22, 2023
Evaluation of perception threshold and pain in patients with Parkinson's disease using PainVision®Kanako Kurihara, Shinsuke Fujioka, Takayasu Mishima, et al.Biomedicines|January 23, 2024
Perry Disease: Bench to Bedside Circulation and a Team ApproachTakayasu Mishima, Junichi Yuasa-Kawada, Shinsuke Fujioka, et al.Journal of Personalized Medicine|August 6, 2021
Personalized Medicine in Parkinson's Disease: New Options for Advanced TreatmentsTakayasu Mishima, Shinsuke Fujioka, Takashi Morishita, et al.Journal of Parkinson'S Disease|February 4, 2017
The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic CriteriaTakayasu Mishima, Jiro Fukae, Shinsuke Fujioka, et al.Internal Medicine (Tokyo, Japan)|March 28, 2022
Polymyalgia Rheumatica Following COVID-19 VaccinationAkira Yokote, Shinsuke Fujioka, Nobutaka Takahashi, et al.Frontiers in Neurology|May 4, 2023
Impact of non-motor fluctuations on QOL in patients with Parkinson's diseaseAsako Kakimoto, Miki Kawazoe, Kanako Kurihara, et al.Pageof 6